Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00158366
Status:
COMPLETED
Last Update Posted:
2018-08-22
First Post:
2005-09-07
Brief Title:
Reducing the Weight of Overweight Schizophrenia Patients
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
A Clinical Trial Of Weight Reduction in Schizophrenia
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine the effectiveness of a group-based behavioral program for weight reduction in overweight and obese schizophrenia patients
Detailed Description:
Researchers have found a link between schizophrenia high blood pressure and insulin resistance this link puts people with schizophrenia at an increased risk for diabetes and obesity Weight reduction and maintenance is essential for decreasing these risks Although data indicate that nonpharmacological interventions for weight loss are viable options studies to determine their effectiveness have not been conducted This study will determine the effectiveness of behavioral training for reducing weight in schizophrenia patients This study will also determine the effects of weight reduction on cardiovascular risk factors in this population
This study comprises two phases In Phase 1 participants will be randomly assigned to receive either behavioral training or social skills training for 14 weeks The behavioral training will teach participants ways to control their diet and increase their physical activity The social skills training will teach participants how to indirectly control their weight by making social contacts and seeking social support After 14 weeks participants in the social skills training group and any participants who have not lost a specified amount of weight will complete the study participants in the behavioral training group who have a 4 or more weight loss will be enrolled in Phase 2 a 24-month program designed to help participants maintain their weight loss All participants in Phase 2 will continue to receive weekly behavioral training but they will be randomly assigned to receive either behavioral training alone or behavioral training combined with biweekly booster treatments where participants discuss their response to different diet and exercise regimens and researchers discuss strategies for increasing ones success with the regimens Interviews self-report scales and blood tests will be used to assess participants at study entry after Phase 1 and at the end of the study Assessments will include quality of life self esteem exercise frequency blood pressure serum lipids and blood glucose
This study comprises two phases In Phase 1 participants will be randomly assigned to receive either behavioral training or social skills training for 14 weeks The behavioral training will teach participants ways to control their diet and increase their physical activity The social skills training will teach participants how to indirectly control their weight by making social contacts and seeking social support After 14 weeks participants in the social skills training group and any participants who have not lost a specified amount of weight will complete the study participants in the behavioral training group who have a 4 or more weight loss will be enrolled in Phase 2 a 24-month program designed to help participants maintain their weight loss All participants in Phase 2 will continue to receive weekly behavioral training but they will be randomly assigned to receive either behavioral training alone or behavioral training combined with biweekly booster treatments where participants discuss their response to different diet and exercise regimens and researchers discuss strategies for increasing ones success with the regimens Interviews self-report scales and blood tests will be used to assess participants at study entry after Phase 1 and at the end of the study Assessments will include quality of life self esteem exercise frequency blood pressure serum lipids and blood glucose
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DSIR 83-ATAP | US NIH GrantContract | None | httpsreporternihgovquickSearchR01MH066068 |
| R01MH066068 | NIH | None | None |